science wire



Results 1 - 50 of 1590.
1 2 3 4 5 ... 32 Next »

Pharmacology - Life Sciences - 24.01.2020
UQ responds to coronavirus outbreak
The University of Queensland has been asked to develop a vaccine for the recent coronavirus outbreak at unprecedented speed, using new technology.

Pharmacology - Life Sciences - 23.01.2020
’A Tornado at the Front Door, a Tsunami at the Back Door’
20-year-old born with rare disease arrives at crossroads: continue toward future most likely leading to early death or become first patient to undergo new gene-and-stem cell therapy developed by Scho

Health - Pharmacology - 23.01.2020
Q&A: Coronavirus outbreak and health policy implications
The outbreak of a novel coronavirus that began in December 2019 in Wuhan, China "is evolving and complex," said the head of the World Health Organization (WHO) after its emergency committee convened

Pharmacology - Health - 23.01.2020

Pharmacology - Innovation - 22.01.2020
Launch of Bristol: Take Drugs Seriously
A series of ground-breaking events that aim to change the way we talk about drug use, policy and harm reduction launches in Bristol tomorrow [Thursday 23 January].

Pharmacology - 22.01.2020

Health - Pharmacology - 22.01.2020
Antiviral treatments inspire new kind of cancer drug
Antiviral treatments inspire new kind of cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice. Stanford virologist Jeffrey Glenn did not set out to tackle cancer. For years, he and his lab have worked to develop new ways of battling viruses like the ones that cause hepatitis delta and the common cold - but the lessons they've learned fighting viruses has led to a new kind of drug that has been effective at treating cancer in mice.

Pharmacology - Health - 21.01.2020
American dreams come true for Fulbright scholars
American dreams come true for Fulbright scholars
University of Queensland scientists are heading ‘stateside' with the support of 2020 Fulbright scholarships.

Pharmacology - Health - 21.01.2020
European Commission approves Roche’s Polivy for people with previously treated aggressive lymphoma
Novel combination regimen includes first-in-class antibody-drug conjugate that specifically targets CD79b Targeted off-the-shelf treatment provides much-needed new option for people with relapsed or

Pharmacology - Health - 20.01.2020
Novartis announces EU approval of Mayzent (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
Patients & Caregivers Healthcare Professionals Society & ESG Mayzent (siponimod) is the first and only oral treatment specifically indicated for patients with secondary progressive multiple s

Pharmacology - Health - 15.01.2020
We must be smarter about how we use antibiotics, says Imperial researcher
Not enough focus is being paid to using antibiotics more appropriately to minimise the threat of drug-resistant bugs, said an expert in a recent talk. Alison Holmes, Professor of Infectious Diseases at Imperial College London and Director of Infection Prevention and Control at Imperial College Healthcare NHS Trust, is leading a newly created centre to tackle drug-resistant infections.

Pharmacology - Health - 15.01.2020
Involving family in care for bipolar disorder helps children and teens stay healthier, longer
In a UCLA-led study, children and adolescents with a high risk for developing bipolar disorder stayed healthier for longer periods when their family members participated in their psychotherapy sessions.

Health - Pharmacology - 15.01.2020
Drug resistance is "up there with climate change" as a global threat
The threat posed by drug resistant infections should be taken as seriously as climate change, says an Imperial expert.

Health - Pharmacology - 15.01.2020
Genome editing at the crossroads of scandal and cure
Genetic modification of babies in China one year ago was universally condemned. At the same time, CRISPR treatments are on their way into our clinics.

Health - Pharmacology - 14.01.2020
New heart disease drug to be made available to NHS patients through ground-breaking collaboration
Up to 30,000 lives could be saved over the next decade thanks to a proposed pioneering government collaboration with pharmaceutical company Novartis to tackle heart disease - a leading cause of death in the UK.

Pharmacology - Health - 13.01.2020
Project aims to improve diagnosis and treatment for patients with anaemia
Ambulatory care specialists at the University of Birmingham, with support from Vifor Pharma UK Limited (VPUK), are working to develop and implement a population based anaemia diagnosis and treatment decision support service for routine healthcare delivery.

Pharmacology - Health - 10.01.2020
New partnership with international pharmaceutical company provides up to $10 million for drug development research at U-M
New partnership with international pharmaceutical company provides up to $10 million for drug development research at U-M
The University of Michigan and Sun Pharma Advanced Research Company have launched a partnership to accelerate the development of potential new medicines for a wide range of diseases. The new venture will provide up to a total of $10 million in financial support and in-kind industry resources to move various promising drug-discovery research projects within the university toward the ultimate goal of new therapies for patients.

Health - Pharmacology - 10.01.2020
Cancer researchers call for ambitious survival targets for the 2020s
The NHS should raise their five-year lung cancer survival targets to 35% by 2030, concludes a new 'state of the nation' policy report conducted by UCL.

Health - Pharmacology - 09.01.2020
First patient for Parkinson's disease trial recruited
First patient for Parkinson’s disease trial recruited
The trial, funded by a 2.1 million grant from the National Institute for Health Research (NIHR) , will test whether a commonly prescribed dementia drug could prevent debilitating falls for people with the disease.

Pharmacology - Health - 09.01.2020
Contaminating a fake rubber hand could help people overcome OCD
Contaminating a fake rubber hand could help people overcome OCD
For Cambridge students For our researchers Business and enterprise Colleges and Departments Email and phone search Give to Cambridge Museums and collections Undergraduate Events and open days Fees an

Health - Pharmacology - 09.01.2020
One out of every two transplant recipients at risk of infection
One out of every two transplant recipients at risk of infection
Swiss researchers, including UNIGE, show that 50% of transplant recipients develop severe infections within a year of the operation, which can lead to death.

Pharmacology - Health - 09.01.2020
Novartis ligelizumab (QGE031) more effective than Xolair at inhibiting immunoglobulin E pathway responsible for chronic spontaneous urticaria
Patients & Caregivers Healthcare Professionals Society & ESG Data show ligelizumab binds to immunoglobulin E (IgE), a key driver of chronic spontaneous urticaria (CSU), with significantly hig

Health - Pharmacology - 08.01.2020
Heart patients in China may be receiving substandard hospital care
A new study suggests that China needs a national strategy to improve hospital care for heart patients. The study, a collaboration among researchers in China and the United States, appears Jan. 8 in the journal JAMA Network Open. Harlan Krumholz, M.D., cardiologist and director of the Yale Center for Outcomes Research and Evaluation (CORE), is co-senior author of the study along with Chinese researcher Jing Li, M.D. The Chinese government has made heart patient care a priority in the past decade, initiating extensive health care reforms.

Pharmacology - Pedagogy - 23.12.2019
Parents: Turkey makes great leftovers-opioids do not
Leftover prescription opioids pose big risks to kids, yet most parents keep their own and their child's unused painkillers even after they're no longer medically necessary for pain.

Pharmacology - 23.12.2019

Pharmacology - Health - 19.12.2019
New MERS vaccine clinical trial starts in Saudi Arabia
The King Abdullah International Medical Research Centre (KAIMRC), in collaboration with the University of Oxford's Jenner Institute has started a Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Health - Pharmacology - 19.12.2019
Sugar not to blame for high risk of heart disease in those at high risk for diabetes
Patients at high risk for diabetes are also at a high risk for heart disease - but not because of higher sugar levels, according to new research led by the University of Glasgow.

Pharmacology - Health - 16.12.2019
Novartis provides update on LUSTER Phase III studies in patients with uncontrolled GINA 4/5 asthma
Patients & Caregivers Healthcare Professionals Society & ESG Pooled analyses of LUSTER 1 and 2 did not support further development of Fevipiprant in asthma as a primary indication Fevipipra

Pharmacology - Health - 16.12.2019

Pharmacology - Health - 13.12.2019
Novartis receives positive CHMP opinion for Beovu (brolucizumab) for the treatment of wet AMD
Patients & Caregivers Healthcare Professionals Society & ESG In two head-to-head clinical trials, patients on Beovu achieved vision gains that were non-inferior to aflibercept at year one 1

Pharmacology - Health - 13.12.2019
Roche announces positive Phase III study results for Tecentriq plus Cotellic and Zelboraf in people with previously untreated BRAF V600 mutation-positive advanced melanoma
Roche today announced the Phase III IMspire150 study, in people with previously untreated BRAF V600 mutation-positive advanced melanoma, met its primary endpoint of progression-free survival (PFS).

Pharmacology - Health - 12.12.2019
Graphene Industry Showcase comes to Manchester
![CDATA[ This week Graphene@Manchester hosted a jam-packed two-day (10-11 December) event showcasing the hottest topics in the field of graphene.

Pharmacology - Health - 12.12.2019
Roche’s fixed-dose subcutaneous combination of Perjeta and Herceptin comparable to intravenous formulations in people with HER2-positive breast cancer
Fixed-dose combination administered under the skin in just minutes, compared to hours with intravenous administration, significantly reducing time spent receiving treatment Phase III FeDeriCa study s

Pharmacology - Health - 11.12.2019
APHINITY six-year results strengthen evidence of clinical benefit with Roche’s Perjeta-based regimen
Greatest improvement in invasive disease-free survival (iDFS) remains in patients at high risk of recurrence, such as those with lymph node-positive disease with a 28% reduction in the risk of recurr

Health - Pharmacology - 11.12.2019
Novartis Kisqali data show superior overall survival compared to fulvestrant and consistent efficacy across advanced breast cancer patient subgroups in MONALEESA-3
Patients & Caregivers Healthcare Professionals Society & ESG MONALEESA-3 paper published today in The New England Journal of Medicine shows statistically significant overall survival results

Health - Pharmacology - 10.12.2019
Roche receives CE Mark for its Accu-Chek SugarView app
Accu-Chek SugarView is the first app that determines blood glucose ranges by taking photos with the smartphone camera without the need of a blood glucose meter.

Pharmacology - Health - 09.12.2019
Novartis Kymriah demonstrates consistent efficacy and safety outcomes in US patients when used in real-world setting
Patients & Caregivers Healthcare Professionals Society & ESG Efficacy in DLBCL confirmed results seen in the pivotal trial despite treatment of a broader population, including older and more

Health - Pharmacology - 09.12.2019
Novartis global survey uncovers profound and often under-reported effects on sickle cell disease patients
Patients & Caregivers Healthcare Professionals Society & ESG Findings from more than 2,000 respondents in 16 countries underscore the debilitating and under-reported effects of sickle cell di

Pharmacology - Health - 08.12.2019
New data demonstrate the continued clinical benefit of fixed-duration, chemotherapy-free Venclexta/Venclyxto-based treatments in chronic lymphocytic leukaemia
In an updated analysis of the CLL14 study, Venclexta/Venclyxto plus Gazyva/Gazyvaro achieved remissions that were sustained over time in people with previously untreated chronic lymphocytic leukaemia

Pharmacology - Health - 06.12.2019
Novartis Phase III data on new inhaled dual combination QMF149 show significant improvement across key asthma outcomes versus monotherapy
Patients & Caregivers Healthcare Professionals Society & ESG Once-daily QMF149 met primary endpoint of lung function improvement and key secondary endpoint of asthma control improvement versu

Pharmacology - Chemistry - 06.12.2019
At 14, U-M undergrad dazzles researchers with scientific prowess
At 14, U-M undergrad dazzles researchers with scientific prowess
oe中文 हिन्दी Portugus Español Share on: Share on Twitter Share on Facebook Share on LinkedIn When 14-year-old Daniel Liu buttons his lab coat and goes to work, he transforms from a teenager into a fearless and persistent researcher.
1 2 3 4 5 ... 32 Next »

This site uses cookies and analysis tools to improve the usability of the site. More information. |